HEALTHCARE HIGHLIGHTS
UK
APPROVES ELI LILLY’ S WEIGHT LOSS PILL
The UK has become the first country in Europe to approve orforglipron, an oral GLP-1 medicine developed by Eli Lilly for weight management and type 2 diabetes, offering an alternative to injections.
“
Vaccinating the first participants with mRNA-1469 marks an important milestone in advancing a vaccine candidate against Bundibugyo ebolavirus”
Stéphane Bancel Chief Executive Officer Moderna
P
& G’ S WELLNESS FOCUS GROWS FOLLOWING US $ 3.8BN DEAL
P & G has expanded its Health Care portfolio with the US $ 3.8bn acquisition of Thorne, tapping into rising consumer interest in personalised wellness.
BRISTOL MYERS SQUIBB ANNOUNCED IT WILL
INVEST US $ 2.3BN INTO A“ MULTI-MODAL MANUFACTURING CAMPUS” IN HOUSTON, TEXAS
healthcare-digital. com 15